These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

211 related articles for article (PubMed ID: 30548064)

  • 1. Antisense Oligonucleotide-Conjugated Nanostructure-Targeting lncRNA MALAT1 Inhibits Cancer Metastasis.
    Gong N; Teng X; Li J; Liang XJ
    ACS Appl Mater Interfaces; 2019 Jan; 11(1):37-42. PubMed ID: 30548064
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The noncoding RNA MALAT1 is a critical regulator of the metastasis phenotype of lung cancer cells.
    Gutschner T; Hämmerle M; Eissmann M; Hsu J; Kim Y; Hung G; Revenko A; Arun G; Stentrup M; Gross M; Zörnig M; MacLeod AR; Spector DL; Diederichs S
    Cancer Res; 2013 Feb; 73(3):1180-9. PubMed ID: 23243023
    [TBL] [Abstract][Full Text] [Related]  

  • 3. T7 Peptide-Conjugated Lipid Nanoparticles for Dual Modulation of Bcl-2 and Akt-1 in Lung and Cervical Carcinomas.
    Cheng X; Yu D; Cheng G; Yung BC; Liu Y; Li H; Kang C; Fang X; Tian S; Zhou X; Liu Q; Lee RJ
    Mol Pharm; 2018 Oct; 15(10):4722-4732. PubMed ID: 30138565
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Long non-coding RNA MUC5B-AS1 promotes metastasis through mutually regulating MUC5B expression in lung adenocarcinoma.
    Yuan S; Liu Q; Hu Z; Zhou Z; Wang G; Li C; Xie W; Meng G; Xiang Y; Wu N; Wu L; Yu Z; Bai L; Li Y
    Cell Death Dis; 2018 May; 9(5):450. PubMed ID: 29670111
    [TBL] [Abstract][Full Text] [Related]  

  • 5. In Vivo Administration of Therapeutic Antisense Oligonucleotides.
    Statello L; Ali MM; Kanduri C
    Methods Mol Biol; 2021; 2254():273-282. PubMed ID: 33326082
    [TBL] [Abstract][Full Text] [Related]  

  • 6. LncRNA MALAT1 promotes migration and invasion of non-small-cell lung cancer by targeting miR-206 and activating Akt/mTOR signaling.
    Tang Y; Xiao G; Chen Y; Deng Y
    Anticancer Drugs; 2018 Sep; 29(8):725-735. PubMed ID: 29916897
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Differentiation of mammary tumors and reduction in metastasis upon Malat1 lncRNA loss.
    Arun G; Diermeier S; Akerman M; Chang KC; Wilkinson JE; Hearn S; Kim Y; MacLeod AR; Krainer AR; Norton L; Brogi E; Egeblad M; Spector DL
    Genes Dev; 2016 Jan; 30(1):34-51. PubMed ID: 26701265
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Delivery of Antisense Oligonucleotides to the Cornea.
    Chau VQ; Hu J; Gong X; Hulleman JD; Ufret-Vincenty RL; Rigo F; Prakash TP; Corey DR; Mootha VV
    Nucleic Acid Ther; 2020 Aug; 30(4):207-214. PubMed ID: 32202944
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The role of lncRNA MALAT1 in bone metastasis in patients with non-small cell lung cancer.
    Liu M; Sun W; Liu Y; Dong X
    Oncol Rep; 2016 Sep; 36(3):1679-85. PubMed ID: 27431200
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Comprehensive Identification of MicroRNAs Regulated by Long Non-coding RNA MALAT1].
    Zhang H; Wang G; Yin R; Qiu M; Xu L
    Zhongguo Fei Ai Za Zhi; 2016 May; 19(5):247-51. PubMed ID: 27215451
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Antisense Oligonucleotide Embedded Context Responsive Nanoparticles Derived from Synthetic Ionizable Lipids for lncRNA Targeted Therapy of Breast Cancer.
    Sarkar S; Moitra P; Bera S; Bhattacharya S
    ACS Appl Mater Interfaces; 2024 Sep; 16(35):45871-45887. PubMed ID: 39163516
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Deconstructing the role of MALAT1 in MAPK-signaling in melanoma: insights from antisense oligonucleotide treatment.
    Feichtenschlager V; Zheng YJ; Ho W; Chen L; Callanan C; Chen C; Lee A; Ortiz J; Rappersberger K; Ortiz-Urda S
    Oncotarget; 2023 May; 14():543-560. PubMed ID: 37235843
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effects of MALAT1 on proliferation and apo- ptosis of human non-small cell lung cancer A549 cells in vitro and tumor xenograft growth in vivo by modulating autophagy.
    Ma J; Wu K; Liu K; Miao R
    Cancer Biomark; 2018; 22(1):63-72. PubMed ID: 29439314
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Drugging the lncRNA MALAT1 via LNA gapmeR ASO inhibits gene expression of proteasome subunits and triggers anti-multiple myeloma activity.
    Amodio N; Stamato MA; Juli G; Morelli E; Fulciniti M; Manzoni M; Taiana E; Agnelli L; Cantafio MEG; Romeo E; Raimondi L; Caracciolo D; Zuccalà V; Rossi M; Neri A; Munshi NC; Tagliaferri P; Tassone P
    Leukemia; 2018 Sep; 32(9):1948-1957. PubMed ID: 29487387
    [TBL] [Abstract][Full Text] [Related]  

  • 15. tRNA-like leader-trailer interaction promotes 3'-end maturation of MALAT1.
    Torabi SF; DeGregorio SJ; Steitz JA
    RNA; 2021 Oct; 27(10):1140-1147. PubMed ID: 34253686
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Towards plant-mediated chemistry - Au nanoparticles obtained using aqueous extract of Rosa damascena and their biological activity in vitro.
    Kyzioł A; Łukasiewicz S; Sebastian V; Kuśtrowski P; Kozieł M; Majda D; Cierniak A
    J Inorg Biochem; 2021 Jan; 214():111300. PubMed ID: 33166865
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Characterization of target mRNA reduction through in situ RNA hybridization in multiple organ systems following systemic antisense treatment in animals.
    Hung G; Xiao X; Peralta R; Bhattacharjee G; Murray S; Norris D; Guo S; Monia BP
    Nucleic Acid Ther; 2013 Dec; 23(6):369-78. PubMed ID: 24161045
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Overexpression of
    Martinez-Terroba E; Plasek-Hegde LM; Chiotakakos I; Li V; de Miguel FJ; Robles-Oteiza C; Tyagi A; Politi K; Zamudio JR; Dimitrova N
    Sci Immunol; 2024 Jun; 9(96):eadh5462. PubMed ID: 38875320
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Analysis of hypoxia-induced noncoding RNAs reveals metastasis-associated lung adenocarcinoma transcript 1 as an important regulator of vascular smooth muscle cell proliferation.
    Brock M; Schuoler C; Leuenberger C; Bühlmann C; Haider TJ; Vogel J; Ulrich S; Gassmann M; Kohler M; Huber LC
    Exp Biol Med (Maywood); 2017 Mar; 242(5):487-496. PubMed ID: 28056547
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Mouse genome-wide association studies and systems genetics uncover the genetic architecture associated with hepatic pharmacokinetic and pharmacodynamic properties of a constrained ethyl antisense oligonucleotide targeting Malat1.
    Pirie E; Ray S; Pan C; Fu W; Powers AF; Polikoff D; Miller CM; Kudrna KM; Harris EN; Lusis AJ; Crooke RM; Lee RG
    PLoS Genet; 2018 Oct; 14(10):e1007732. PubMed ID: 30372444
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.